Reports Q3 revenue $20.69M, consensus $21.78M. “We demonstrated continued growth and meaningful progress this quarter, resulting from a strengthened leadership team and strategic changes to enhance our commercial organization,” said Antony Koblish, co-founder and CEO.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TELA:
- TELA Earnings this Week: How Will it Perform?
- TELA Bio Appoints William Plovanic to Board
- Tela Bio’s OviTex PRS Study: A New Frontier in Breast Reconstruction
- Tela Bio’s OviTex Study: A Potential Game-Changer in Hernia Repair
- Tela Bio’s OviTex Study: A Potential Game-Changer for Hiatal Hernia Treatment